17 research outputs found

    Π’Ρ‹Π±ΠΎΡ€ ΠΌΠ΅Ρ‚ΠΎΠ΄Π° измСрСния Π²Π½ΡƒΡ‚Ρ€ΠΈΠ³Π»Π°Π·Π½ΠΎΠ³ΠΎ давлСния для ΠΎΡ†Π΅Π½ΠΊΠΈ Π³ΠΈΠΏΠΎΡ‚Π΅Π½Π·ΠΈΠ²Π½ΠΎΠΉ эффСктивности Π°Π½Ρ‚ΠΈΠ³Π»Π°ΡƒΠΊΠΎΠΌΠ½Ρ‹Ρ… ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΉ

    Get PDF
    Purpose of this study β€” to compare the results of different tonometry methods before surgical treatment of glaucoma and in the early postoperative period.The study was conducted on a group of 50 patients (50 eyes) aged 55 to 80 years with uncompensated primary open-angle glaucoma, who were admitted to in-patient department for glaucoma surgery. Patients were examined using bidirectional applanation tonometry of the cornea performed on Ocular Response Analyzer, pneumotonometry on Canon TX-20P device, and with Icare tonometer. These studies were carried out on the day before the surgery, the next day, and 2 weeks after the operation.Significant differences in tonometry readings were revealed between all tested devices at high intraocular pressure (IOP) levels (before glaucoma surgery). Significant differences were also found in IOP values obtained with Icare tonometer in the central zone of the cornea and in the middle periphery in the nasal and temporal sectors. A significant difference between the indicators remained on the next day after surgery, except for the Icare readings. After two weeks, the tonometric parameters did not differ significantly from each other.Corneal compensated IOP (IOPcc) is the most important tonometric indicator in clinical practice because it takes into account the individual biomechanical characteristics of the patient’s cornea. When examining patients with glaucoma, the IOPcc indicator significantly differed in uncompensated IOP, which is important for determining the correct treatment tactics. When assessing the level of IOP after surgery this trend persisted, indicating a systematic underestimation of IOP level (overestimation of the effect of glaucoma surgery). The reliability of the study is confirmed by the results of measurements on unoperated fellow eyes (control).ЦСль β€” ΡΡ€Π°Π²Π½ΠΈΡ‚ΡŒ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ Ρ€Π°Π·Π½Ρ‹Ρ… ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² Ρ‚ΠΎΠ½ΠΎΠΌΠ΅Ρ‚Ρ€ΠΈΠΈ Π΄ΠΎ хирургичСского лСчСния Π³Π»Π°ΡƒΠΊΠΎΠΌΡ‹ ΠΈ Π² Ρ€Π°Π½Π½Π΅ΠΌ послСопСрационном ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅. ИсслСдованиС ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π² Π³Ρ€ΡƒΠΏΠΏΠ΅ ΠΈΠ· 50 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² (50 Π³Π»Π°Π·) Π² возрастС ΠΎΡ‚ 55 Π΄ΠΎ 80 Π»Π΅Ρ‚ с нСкомпСнсированной ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΡ‚ΠΊΡ€Ρ‹Ρ‚ΠΎΡƒΠ³ΠΎΠ»ΡŒΠ½ΠΎΠΉ Π³Π»Π°ΡƒΠΊΠΎΠΌΠΎΠΉ, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ поступали Π² стационар для провСдСния Π°Π½Ρ‚ΠΈΠ³Π»Π°ΡƒΠΊΠΎΠΌΠ½ΠΎΠΉ ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ. Выполняли исслСдованиС с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ Π΄Π²ΡƒΠ½Π°ΠΏΡ€Π°Π²Π»Π΅Π½Π½ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ°ΠΏΠ»Π°Π½Π°Ρ†ΠΈΠΈ Ρ€ΠΎΠ³ΠΎΠ²ΠΈΡ†Ρ‹ Π½Π° биомСханичСском Π°Π½Π°Π»ΠΈΠ·Π°Ρ‚ΠΎΡ€Π΅ Ocular Response Analyzer, Π±Π΅ΡΠΊΠΎΠ½Ρ‚Π°ΠΊΡ‚Π½ΡƒΡŽ Ρ‚ΠΎΠ½ΠΎΠΌΠ΅Ρ‚Ρ€ΠΈΡŽ ΠΏΡ€ΠΈΠ±ΠΎΡ€ΠΎΠΌ Canon TX-20P ΠΈ ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½ΠΈΠ΅ Ρ‚ΠΎΠ½ΠΎ- ΠΌΠ΅Ρ‚Ρ€ΠΎΠΌ Icare. Π­Ρ‚ΠΈ исслСдования ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π·Π° дСнь Π΄ΠΎ провСдСния Π°Π½Ρ‚ΠΈΠ³Π»Π°ΡƒΠΊΠΎΠΌΠ½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π²Π°, Π½Π° ΡΠ»Π΅Π΄ΡƒΡŽΡ‰ΠΈΠΉ дСнь ΠΈ Ρ‚Π°ΠΊΠΆΠ΅ Ρ‡Π΅Ρ€Π΅Π· 2 Π½Π΅Π΄Π΅Π»ΠΈ послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ. ΠŸΡ€ΠΈ высоких значСниях Π²Π½ΡƒΡ‚Ρ€ΠΈΠ³Π»Π°Π·Π½ΠΎΠ³ΠΎ давлСния (Π’Π“Π”) (Π΄ΠΎ провСдСния Π°Π½Ρ‚ΠΈΠ³Π»Π°ΡƒΠΊΠΎΠΌΠ½ΠΎΠΉ ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ) Π±Ρ‹Π»ΠΈ выявлСны достовСрныС различия тономСтричСских ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ ΠΌΠ΅ΠΆΠ΄Ρƒ всСми ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹ΠΌΠΈ ΠΏΡ€ΠΈΠ±ΠΎΡ€Π°ΠΌΠΈ. Π’Π°ΠΊΠΆΠ΅ Π±Ρ‹Π»ΠΈ выявлСны достовСрныС различия Π² показатСлях Π’Π“Π” ΠΏΡ€ΠΈ Ρ‚ΠΎΠ½ΠΎΠΌΠ΅Ρ‚Ρ€ΠΈΠΈ Icare Π² Ρ†Π΅Π½Ρ‚Ρ€Π°Π»ΡŒΠ½ΠΎΠΉ Π·ΠΎΠ½Π΅ Ρ€ΠΎΠ³ΠΎΠ²ΠΈΡ†Ρ‹ ΠΈ Π½Π° срСднСй ΠΏΠ΅Ρ€ΠΈΡ„Π΅Ρ€ΠΈΠΈ Π² носовом ΠΈ височном сСкторах. На ΡΠ»Π΅Π΄ΡƒΡŽΡ‰ΠΈΠΉ дСнь послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ достовСрная Ρ€Π°Π·Π½ΠΈΡ†Π° ΠΌΠ΅ΠΆΠ΄Ρƒ показатСлями ΡΠΎΡ…Ρ€Π°Π½ΡΠ»Π°ΡΡŒ, Π·Π° ΠΈΡΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅ΠΌ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Icare. Π§Π΅Ρ€Π΅Π· 2 Π½Π΅Π΄Π΅Π»ΠΈ послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ тономСтричСскиС ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ ΠΌΠ΅ΠΆΠ΄Ρƒ собой достовСрно Π½Π΅ Ρ€Π°Π·Π»ΠΈΡ‡Π°Π»ΠΈΡΡŒ. Π ΠΎΠ³ΠΎΠ²ΠΈΡ‡Π½ΠΎ-компСнсированноС Π’Π“Π” являСтся Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½Ρ‹ΠΌ Π² клиничСском ΠΏΠ»Π°Π½Π΅ тономСтричСским ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΌ, ΠΏΠΎΡΠΊΠΎΠ»ΡŒΠΊΡƒ ΡƒΡ‡ΠΈΡ‚Ρ‹Π²Π°Π΅Ρ‚ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡƒΠ°Π»ΡŒΠ½Ρ‹Π΅ особСнности Ρ„ΠΈΠ±Ρ€ΠΎΠ·Π½ΠΎΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡ‡ΠΊΠΈ Π³Π»Π°Π·Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ². ΠŸΡ€ΠΈ обслСдовании ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с Π³Π»Π°ΡƒΠΊΠΎΠΌΠΎΠΉ этот ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒ достовСрно отличаСтся ΠΏΡ€ΠΈ нСкомпСнсированном Π’Π“Π”, Ρ‡Ρ‚ΠΎ Π²Π°ΠΆΠ½ΠΎ для опрСдСлСния ΠΏΡ€Π°Π²ΠΈΠ»ΡŒΠ½ΠΎΠΉ Ρ‚Π°ΠΊΡ‚ΠΈΠΊΠΈ лСчСния. ΠŸΡ€ΠΈ ΠΎΡ†Π΅Π½ΠΊΠ΅ Π’Π“Π” послС ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ данная тСндСнция ΡΠΎΡ…Ρ€Π°Π½ΡΠ»Π°ΡΡŒ, Ρ‡Ρ‚ΠΎ ΡƒΠΊΠ°Π·Ρ‹Π²Π°Π΅Ρ‚ Π½Π° ΡΠΈΡΡ‚Π΅ΠΌΠ°Ρ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Π½Π΅Π΄ΠΎΠΎΡ†Π΅Π½ΠΊΡƒ ΠΎΡ„Ρ‚Π°Π»ΡŒΠΌΠΎΡ‚ΠΎΠ½ΡƒΡΠ° (ΠΏΠ΅Ρ€Π΅ΠΎΡ†Π΅Π½ΠΊΡƒ эффСкта ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΈ). Π”ΠΎΡΡ‚ΠΎΠ²Π΅Ρ€Π½ΠΎΡΡ‚ΡŒ исслСдования подтвСрТдаСтся Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌΠΈ исслСдова- ния Π½Π° ΠΏΠ°Ρ€Π½Ρ‹Ρ… Π½Π΅ΠΎΠΏΠ΅Ρ€ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹Ρ… Π³Π»Π°Π·Π°Ρ…

    Transgenerational Phenomenon of Genomic Instability in Children of Irradiated Parents during ChNPP

    No full text
    Study of families irradiated during the accident at the Chernobyl nuclear power plant revealed significantly increased levels of aberrant genomes not only in irradiated of low doses parents (fathers-liquidators, fathers and mothers from territories contaminated with radionuclides (n = 106, p < 0.01)), but also in their children born in 1987-2004 after the accident (n = 159, p < 0.05). These children with different somatic pathologies were examined in the Children's Center of Radiation Protection of the Institute of Pediatrics and Children's Surgery of the RF Ministry of Public Health (head. - prof. Baleva L. S.). This is indicative of the transgenerational phenomenon of genomic instability. To elucidate this phenomenon, experiments were undertaken to model genomic instability by using fractionated in vitro Ξ³-irradiation (137Cs) of peripheral blood lymphocytes samples of the children and their parents at doses of 10, 20 and 30 cGy. The spectrum and frequency of chromosomes aberrations were studied in the 1st and 2nd cell generations. The children of irradiated parents (n=6). Children born from unirradiated parents (n = 3) served as a control. Parents: irradiated fathers (n = 3) and unirradiated mothers (n = 3). Single doses were 10 cGy, 20 cGy, 30 cGy. Fractional doses were 10 cGy + 10 cGy and 10 cGy + 10 cGy + 10 cGy. Blood samples were irradiated at 24 h intervals. Before culturing all blood samples were stored at 370 C. Cultivation of lymphocytes was carried out for 48 h and 72 h with the use of 5-BrdU added to differentiate between mitosis 1 and mitosis 2. Average frequency of aberrant genomes were significantly increased at all doses in the children of irradiated parents, as compared to the children born from un-irradiated parents. The magnitude of the elevation of the individual frequencies of aberrant genomes is accordance on the initial levels of the genome aberrations. This is indicative of individual radiosensitivity probably depending on genotypic peculiarities, initial state (sensitivity) of the genome, pathophysiological processes in the organism of children. Amplification of cells with single-break chromosome aberrations in the mitosis 2, as compared to mitosis 1 suggests the replication mechanism of realization of potential damage in DNA and the occurrence of genomic instability in succeeding cell generations

    Adjuvant Therapy for Stages II and III Colon Cancer: Risk Stratification, Treatment Duration, and Future Directions

    No full text
    Background: To date, the role of adjuvant systemic therapy in stages ii and iii colon cancer remains a topic of interest and debate. The objective of the present review was to assess the most recent data, specifically addressing methods of risk stratification, duration of therapy, and future directions. Methods: PubMed and medline were searched for literature pertinent to adjuvant chemotherapy in either stage ii or stage iii colorectal cancer. Summary: Locoregional disease, histopathology, age, laterality, and a number of other biologic and molecular markers appear to have a role in disease risk stratification. The duration of adjuvant therapy for stage iii disease can vary based on risk factors, but use of adjuvant therapy and duration of therapy in stage ii disease remain controversial. Future directions should include genomic assays and improved study design to provide concrete evidence about the duration of adjuvant folfox or capox and about other types of chemotherapy and immunotherapy

    Adenoid Hypertrophy Risk in Children Carriers of G-1082A Polymorphism of IL-10 Infected with Human Herpes Virus (HHV6, EBV, CMV)

    No full text
    Adenoid hypertrophy (AH) is considered one of the most common diseases in the ear, nose and throat (ENT) practice. The cause of adenoid hypertrophy in children is still unknown. The main aim of the current study was to investigate IL-10 (interleukin 10) gene polymorphisms and human herpesviruses 6 (HHV6), cytomegalovirus (CMV), and Epstein–Barr virus (EBV) infections in children with AH. A total of 106 children with adenoid hypertrophy and 38 healthy children aged 2–11 years were included in this study. All children with adenoid hypertrophy were divided into three subgroups depending on the adenoid size. The viruses were determined via quantitative real-time polymerase chain reaction (PCR) using commercially available kits (QIAGEN, Germany). HHV6 was more frequently detected in patients with AH compared with CMV and EBV. Among the three subgroups of children with AH, HH6 and EBV were prevalent in the children with the largest adenoid size. The frequency of genotype GG tended to be higher in the control group of children. We found significantly higher frequencies of the G allele and GG and GA genotypes for IL-10 rs1800896 in the subgroup of children with the smallest size of adenoid compared with other subgroups. In conclusion, HHV6 and EBV infection could contribute to the adenoid size. The genotype GG for IL-10 rs1800896 could contribute to the resistance to adenoid hypertrophy and the spread of the adenoid tissue. Β© 2022 by the authors. Licensee MDPI, Basel, Switzerland

    Adenoid Hypertrophy Risk in Children Carriers of G-1082A Polymorphism of <i>IL-10</i> Infected with Human Herpes Virus (HHV6, EBV, CMV)

    No full text
    Adenoid hypertrophy (AH) is considered one of the most common diseases in the ear, nose and throat (ENT) practice. The cause of adenoid hypertrophy in children is still unknown. The main aim of the current study was to investigate IL-10 (interleukin 10) gene polymorphisms and human herpesviruses 6 (HHV6), cytomegalovirus (CMV), and Epstein–Barr virus (EBV) infections in children with AH. A total of 106 children with adenoid hypertrophy and 38 healthy children aged 2–11 years were included in this study. All children with adenoid hypertrophy were divided into three subgroups depending on the adenoid size. The viruses were determined via quantitative real-time polymerase chain reaction (PCR) using commercially available kits (QIAGEN, Germany). HHV6 was more frequently detected in patients with AH compared with CMV and EBV. Among the three subgroups of children with AH, HH6 and EBV were prevalent in the children with the largest adenoid size. The frequency of genotype GG tended to be higher in the control group of children. We found significantly higher frequencies of the G allele and GG and GA genotypes for IL-10 rs1800896 in the subgroup of children with the smallest size of adenoid compared with other subgroups. In conclusion, HHV6 and EBV infection could contribute to the adenoid size. The genotype GG for IL-10 rs1800896 could contribute to the resistance to adenoid hypertrophy and the spread of the adenoid tissue

    MODERN APPROACHES IN THE DIAGNOSIS AND CONSERVING THERAPY OF ADENOMYOSIS

    No full text
    At this point in modern gynecology there are no uniform standards in the diagnosis and treatment of adenomyosis. This problem requires special attention, since there is a tendency to increase the incidence of this disease, especially in younger women. The paper presents the data in the literature about the different methods of diagnosis (hysteroscopy, ultrasound, MRI), and provides criteria for evaluation of these methods. Of greatest interest are the data of foreign authors on a new method of treatment of adenomyosis – magnetic resonance- guided focused ultrasound surgery
    corecore